Cargando…

Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB

Repurposing has gained momentum globally and become an alternative avenue for drug discovery because of its better success rate, and reduced cost, time and issues related to safety than the conventional drug discovery process. Several drugs have already been successfully repurposed for other clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brindha, Sridharan, Sundaramurthi, Jagadish Chandrabose, Velmurugan, Devadasan, Vincent, Savariar, Gnanadoss, John Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2016
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312000/ https://www.ncbi.nlm.nih.gov/pubmed/28275291 http://dx.doi.org/10.6026/97320630012368

Ejemplares similares

Structure based virtual screening to identify inhibitors against MurE Enzyme of Mycobacterium tuberculosis using AutoDock Vina
por: Singh, Shilpi, et al.
Publicado: (2014)

Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Insilico analysis and molecular docking of resuscitation promoting factor B (RpfB) protein of Mycobacterium tuberculosis
por: Mylliemngap, Baphilinia Jones, et al.
Publicado: (2012)

Architecture and genomic arrangement of the MurE–MurF bacterial cell wall biosynthesis complex
por: Shirakawa, Karina T., et al.
Publicado: (2023)

Designing of Protein Kinase C β-II Inhibitors against Diabetic complications: Structure Based Drug Design, Induced Fit docking and analysis of active site conformational changes
por: Vijayakumar, Balakrishnan, et al.
Publicado: (2012)

An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis
por: Osman, Khadijo, et al.
Publicado: (2012)

Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase
por: Guzman, Juan D., et al.
Publicado: (2015)

Homology modeling, molecular docking and electrostatic potential analysis of MurF ligase from Klebsiella pneumonia
por: Sivaramakrishnan, Venkatabalasubramanian, et al.
Publicado: (2012)

Active compound from the leaves of Vitex negundo L. shows anti-inflammatory activity with evidence of inhibition for secretory Phospholipase A(2) through molecular docking
por: Vinuchakkaravarthy, Thangaraj, et al.
Publicado: (2011)

Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics
por: Guzman, Juan David, et al.
Publicado: (2011)

Structure based design of compounds from natural sources for diabetes and inflammation
por: Suhitha, Sivasubramanian, et al.
Publicado: (2012)

3D-QSAR studies on fluroquinolones derivatives as inhibitors for tuberculosis
por: Bhattacharjee, Atanu, et al.
Publicado: (2012)

Molecular docking analysis of new generation cephalosporins interactions with recently known SHV-variants
por: Khan, Asad Ullah, et al.
Publicado: (2011)

Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer
por: Dash, Raju, et al.
Publicado: (2015)

Selection of an improved HDAC8 inhibitor through structure-based drug design
por: Vijayakumar, Balakrishnan, et al.
Publicado: (2011)

Molecular docking NS4B of DENV 1-4 with known bioactive phyto-chemicals
por: Paul, Anubrata, et al.
Publicado: (2016)

Molecular docking analysis of UniProtKB nitrate reductase enzyme with known natural flavonoids
por: Shaik, Ayub, et al.
Publicado: (2016)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Specificity Determinants for Lysine Incorporation in Staphylococcus aureus Peptidoglycan as Revealed by the Structure of a MurE Enzyme Ternary Complex
por: Ruane, Karen M., et al.
Publicado: (2013)

Uncovering potential Drug Targets for Tuberculosis using Protein Networks
por: Raman, Mohana Priya, et al.
Publicado: (2012)

Exploring GpG bases next to anticodon in tRNA subsets
por: Srinivasan, Thangavelu, et al.
Publicado: (2013)

Homology modeling, active site prediction, and targeting the anti hypertension activity through molecular docking on endothelin – B receptor domain
por: Rayalu, Daddam Jayasimha, et al.
Publicado: (2012)

Interaction pattern for the complex of B-DNA Fullerene compounds with a set of known replication proteins using docking study
por: Firdaus, Sumbul, et al.
Publicado: (2015)

DDTRP: Database of Drug Targets for Resistant Pathogens
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Designing novel inhibitors against Mycobacterium tuberculosis FadA5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds
por: Jaiswal, Atul Kumar, et al.
Publicado: (2018)

Structural basis for the in vitro known acyl-depsipeptide 2 (ADEP2) inhibition to Clp 2 protease from Mycobacterium tuberculosis
por: Khandekar, Natasha, et al.
Publicado: (2016)

Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis
por: Santhi, Natchimuthu, et al.
Publicado: (2011)

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Insights from the docking and molecular dynamics simulation of the Phosphopantetheinyl transferase (PptT) structural model from Mycobacterium tuberculosis
por: Rohini, Karunakaran, et al.
Publicado: (2013)

Implication from the predicted docked interaction of sigma H and exploration of its interaction with RNA polymerase in Mycobacterium tuberculosis
por: Gupta, Aayatti Mallick, et al.
Publicado: (2015)

Identification of inhibitors against α-Isopropylmalate Synthase of Mycobacterium tuberculosis using docking-MM/PBSA hybrid approach
por: Pandey, Preeti, et al.
Publicado: (2017)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

Molecular Docking of Known Carcinogen 4- (Methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) with Cyclin Dependent Kinases towards Its Potential Role in Cell Cycle Perturbation
por: Haneef, Mohd, et al.
Publicado: (2014)

DNA polymerase III α subunit from Mycobacterium tuberculosis H37Rv: Homology modeling and molecular docking of its inhibitor
por: Chhabra, Gagan, et al.
Publicado: (2011)

Effect of HIV-1 Subtype C integrase mutations implied using molecular modeling and docking data
por: Sachithanandham, Jaiprasath, et al.
Publicado: (2016)

Virtual screening of plant derived compounds for aldose reductase inhibition using molecular docking
por: Muppalaneni, Naresh Babu, et al.
Publicado: (2012)

Molecular docking based virtual screening of compounds for inhibiting sortase A in L.monocytogenes
por: Rashidieh, Behnam, et al.
Publicado: (2015)

Proposed Algorithm for Integrated Management of TB-SARS-CoV-2 Co-Infection in a TB-Endemic Country
por: Mertaniasih, Ni Made, et al.
Publicado: (2022)

High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus
por: Tamilvanan, Thangaraju, et al.
Publicado: (2013)

Shape based virtual screening and molecular docking towards designing novel pancreatic lipase inhibitors
por: Veeramachaneni, Ganesh Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_43enhgnhl7kerdu469c06tf20m